Literature DB >> 8555706

Hepatocellular carcinoma associated with lupoid hepatitis: a review of Japanese reports.

T Sakaguchi1, S Nakamura, S Suzuki, R Nishiyama, H Konno, S Baba, H Muro, T Kawasaki.   

Abstract

A 66-year-old woman was diagnosed as having lupoid hepatitis due to the presence of hypergammaglobulinemia, lupus erythematosus cells, and positivity for antinuclear, anti-DNA, and anti-smooth muscle antibodies. None of the serum hepatitis B markers were positive. Symptomatic relief was obtained by prednisolone administration. Five years after the diagnosis of lupoid hepatitis, hepatocellular carcinoma (HCC) was detected by ultrasonography and computed tomography, after which hepatectomy was performed. Although transcatheter arterial embolization was done on two occasions and repeat hepatectomy was performed twice for recurrent HCC, her liver function remained good with the prednisolone treatment. Antibody for hepatitis C virus has been negative since our first check in 1992. As of this writing, the patient has been alive and well 6 years and 2 months after the first hepatectomy. There have been no previous reports of 6-year survival after hepatectomy for HCC associated with lupoid hepatitis.

Entities:  

Mesh:

Year:  1995        PMID: 8555706     DOI: 10.1007/bf00311464

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  13 in total

1.  Lupoid hepatitis.

Authors:  D C COWLING; I R MACKAY; L I TAFT
Journal:  Lancet       Date:  1956-12-29       Impact factor: 79.321

2.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

3.  Idiopathic chronic active hepatitis and hepatic cell carcinoma.

Authors:  I Bjarnason; B Magnusson; S Bjornsson
Journal:  Acta Med Scand       Date:  1982-05

4.  Effectiveness of periodic checkup by ultrasonography for the early diagnosis of hepatocellular carcinoma.

Authors:  S Tanaka; T Kitamura; K Nakanishi; S Okuda; H Yamazaki; T Hiyama; I Fujimoto
Journal:  Cancer       Date:  1990-11-15       Impact factor: 6.860

5.  Recent advances in ultrasonographic diagnosis of hepatocellular carcinoma.

Authors:  S Tanaka; T Kitamura; K Nakanishi; S Okuda; J Kojima; I Fujimoto
Journal:  Cancer       Date:  1989-04-01       Impact factor: 6.860

6.  Resected case of hepatocellular carcinoma associated with lupoid hepatitis.

Authors:  Y Motoo; T Wakatsuki; N Tanaka; Y Hinoue; K Kobayashi; N Hattori; O Matsui; R Izumi; Y Nakanuma; G Ohta
Journal:  J Gastroenterol Hepatol       Date:  1989 May-Jun       Impact factor: 4.029

7.  Primary liver cell carcinoma complicating autoimmune chronic active hepatitis.

Authors:  A W Jakobovits; P R Gibson; F J Dudley
Journal:  Dig Dis Sci       Date:  1981-08       Impact factor: 3.199

Review 8.  A case of primary liver cell cancer complicating lupoid hepatitis.

Authors:  Y Satake; K Takada; K Ikeda; T Shiosaka; S Fujita; Y Kobayashi
Journal:  Jpn J Med       Date:  1988-02

9.  Suppression of natural killer activity in patients treated with cisplatin and methylprednisolone.

Authors:  K Takahashi; N Saijo; M Kimata; Y Sasaki; J Fujita; H Futami; E Shimizu; K Eguchi; T Shinkai; K Tominaga
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

10.  Type 2 autoimmune hepatitis and hepatitis C virus infection.

Authors:  M Lenzi; G Ballardini; M Fusconi; F Cassani; L Selleri; U Volta; D Zauli; F B Bianchi
Journal:  Lancet       Date:  1990-02-03       Impact factor: 79.321

View more
  1 in total

Review 1.  Hepatocellular carcinoma and other malignancies in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2013-01-10       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.